Importantly PSMA PET/CT yields a semiquantitative measurement of the standardized uptake value (SUV) of the radiotracer, which is useful in oncology for detecting primary or metastatic sites of PCa, differentiating between benign and malignant tumors, comparing lesions seen on CT scans, planning treatment, monitoring the response to treatment and/or detecting recurrent disease (15). The gene discussed is FOLH1; the disease is posterior cortical atrophy.